Clinical Trial Update: A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]

View source ↗

Summary

A multicenter clinical trial (MESOMEGA) is evaluating optimization of microembolic signal classification in stroke using a double-blind, multiparametric assessm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Universidade do Porto | Conditions: Microemboli, Stroke | Status: ENROLLING_BY_INVITATION